Please Upload related files below
Fill in below.
Tell us the stocks you own using SnapTrade, and we will keep you informed about class action litigation related to your stocks. We monitor critical case developments that may affect the price of your shares and your possible monetary recovery. SnapTrade only shares the tickers you own and your transaction history, not your account numbers. Using SnapTrade and participating in our monitoring service is free and does not create any attorney-client relationship or obligation on your part.
Don’t miss out on possible monetary recovery - link your brokerage account with SnapTrade.
Spruce Point Capital Management (“Spruce Point”) published a report on Tempus, on May 28, 2025, describing a number of “concerns” about the Company. Among other issues, the Spruce Point report asserted that the Company used “aggressive accounting and financial reporting”; that several members of the Company’s Board and “other executives have been associated with troubled companies that restated financial results”; and that “[k]ey strategic partnerships and deal announcement[s] with AstraZeneca and Pathos AI merit scrutiny.”
Following this news, Tempus’s stock price fell sharply during intraday trading on the same day.